Microbiology & Infectious Diseases

Discover how machine learning shows high accuracy for HIV prediction but needs better validation before use in STI clinical practice.

Three monoclonal antibodies targeting monkeypox A35 protein protect mice and improve outcomes, highlighting potential for new therapies.

A new study suggests that the common cold may boost children’s antiviral defences, lowering the risk and severity of COVID-19.

FMT and microbiome therapies significantly outperform antibiotics in recurrent C. difficile infection, with cure rates up to 91% and favourable long-term safety.

Respiratory viruses such as influenza and SARS-CoV-2 can awaken dormant breast cancer cells, driving metastasis and raising mortality risk in cancer survivors, new research finds.

A Ugandan trial has found artemether-lumefantrine less effective than other ACTs, with malaria resistance mutations linked to delayed parasite clearance.

A Phase 1 USA trial finds novel oral polio vaccines nOPV1 and nOPV3 to be safe, highly immunogenic, and comparable to Sabin-strain vaccines, paving the way for Phase 2 studies.

Portable $2 test detects deadly infections from a drop of blood within 15 minutes, with unmatched sensitivity.